The regulation of lupus-associated autoantibodies: Immunoglobulin transgenic models

Current Opinion in Immunology

Volumn 15, Issue 6, 2003, Pages 709-717

  Fields, Michele L ^a   Erikson, Jan ^a  

^a WISTAR INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; AUTOANTIBODY; DNA ANTIBODY; DOUBLE STRANDED DNA; IMMUNOGLOBULIN HEAVY CHAIN; IMMUNOGLOBULIN LIGHT CHAIN; MONOCLONAL ANTIBODY; RECEPTOR; RHEUMATOID FACTOR; TOLL LIKE RECEPTOR;

ANTIBODY PRODUCTION; ANTIGEN ANTIBODY COMPLEX; AUTOIMMUNITY; B LYMPHOCYTE; B LYMPHOCYTE ACTIVATION; BONE MARROW; CELL FATE; CELL MATURATION; CHROMOSOME MICRODISSECTION; GENE DELETION; GERMINAL CENTER; IMMUNOLOGICAL TOLERANCE; IMMUNOREACTIVITY; IMMUNOREGULATION; LUPUS ERYTHEMATOSUS; LYMPHOCYTE ACTIVATION; LYMPHOCYTE FUNCTION; NONHUMAN; NUCLEOSOME; REVIEW; RNA EDITING; SOMATIC HYPERMUTATION; STIMULUS RESPONSE; TRANSGENIC MOUSE;

EID: 0242407710     PISSN: 09527915     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.coi.2003.09.016     Document Type: Review

References (76)

1. Tan E.M. Antinuclear antibodies: diagnostic markers for autoimmune diseases and probes for cell biology. Adv. Immunol. 44:1989;93-151.
2. Goodnow C.C. Balancing immunity and tolerance: deleting and tuning lymphocyte repertoires. Proc. Natl. Acad. Sci. U.S.A. 93:1996;2264-2271.
3. Schmidt K.N., Cyster J.G. Follicular exclusion and rapid elimination of hen egg lysozyme autoantigen-binding B cells are dependent on competitor B cells, but not on T cells. J. Immunol. 162:1999;284-291.
4. DeGiorgio L.A., Konstantinov K.N., Lee S.C., Hardin J.A., Volpe B.T., Diamond B. A subset of lupus anti-DNA antibodies cross-reacts with the NR2 glutamate receptor in systemic lupus erythematosus. Nat. Med. 7:2001;1189-1193.
5. Li H., Jiang Y., Cao H., Radic M., Prak E., Weigert M. Regulation of anti-phosphatidylserine antibodies. Immunity. 18:2003;185-192 Anti-DNA/phosphatidylserine B cells in transgenic mice appear regulated by receptor editing, with evidence for association of the transgenic H chain with a limited repertoire of endogenous L chains. Importantly, this study highlights the crossreactive nature of anti-DNA Abs and the difficulty in identifying the in vivo tolerogen. Moreover, it supports the hypothesis that anti-dsDNA B cells may be tolerized by encounters with Ags on apoptotic cells.
6. Rosen A., Casciola-Rosen L., Ahearn J. Novel packages of viral and self-antigens are generated during apoptosis. J. Exp. Med. 181:1995;1557-1561.
7. Cocca B., Cline A., Radic M. Blebs and apoptotic bodies are B cell autoantigens. J. Immunol. 169:2002;159-166 Anti-dsDNA Abs bind to large membrane blebs on apoptotic cells, providing convincing evidence that apoptotic cells could be a physiologically relevant source for nuclear Ag presentation.
8. Cohen P., Caricchio R., Abraham V., Camenisch T., Jennette J., Roubey R., Earp H.S., Matsushima G., Reap E. Delayed apoptotic cell clearance and lupus-like autoimmunity in mice lacking the c-mer membrane tyrosine kinase. J. Exp. Med. 196:2002;135-140 C-mer is a tyrosine kinase involved in the recognition and clearance of apoptotic debris. Mice lacking the intracellular domain of c-mer have increased titers of anti-dsDNA auto-Abs, providing more evidence for the link between defects in apoptosis/apoptotic clearance and anti-dsDNA Ab production. Immunization with apoptotic cells does not accelerate anti-dsDNA auto-Ab production, indicating that endogenous apoptotic cells generated in the mice themselves are sufficient for auto-Ab production.
9. Rosen A., Casciola-Rosen L. Clearing the way to mechanisms of autoimmunity. Nat. Med. 7:2001;664-665.
10. Walport M. Lupus, DNase and defective disposal of cellular debris. Nat. Genet. 25:2000;135-136.
11. Gay D., Saunders T., Camper S., Weigert M. Receptor editing: an approach by autoreactive B cells to escape tolerance. J. Exp. Med. 177:1993;999-1008.
12. Radic M.Z., Erikson J., Litwin S., Weigert M. B lymphocytes may escape tolerance by revising their antigen receptors. J. Exp. Med. 177:1993;1165-1173.
13. Prak E.L., Trounstine M., Huszar D., Weigert M. Light chain editing in κ-deficient animals: a potential mechanism of B cell tolerance. J. Exp. Med. 180:1994;1805-1815.
14. Chen C., Radic M.Z., Erikson J., Camper S.A., Litwin S., Hardy R.R., Weigert M. Deletion and editing of B cells that express antibodies to DNA. J. Immunol. 152:1994;1970-1982.
15. Chen C., Nagy Z., Prak E., Weigert M. Immunoglobulin heavy chain gene replacement: a mechanism of receptor editing. Immunity. 3:1995;747-755.
16. Chen C., Prak E.L., Weigert M. Editing disease-associated autoantibodies. Immunity. 6:1997;97-105.
17. ••].
18. Pewzner-Jung Y., Friedmann D., Sonoda E., Jung S., Rajewsky K., Eilat D. B cell deletion, anergy, and receptor editing in "knock in" mice targeted with a germline-encoded or somatically mutated anti-DNA heavy chain. J. Immunol. 161:1998;4634-4645.
19. Yachimovich N., Mostoslavsky G., Yarkoni Y., Verbovetski I., Eilat D. The efficiency of B cell receptor (BCR) editing is dependent on BCR light chain rearrangement status. Eur. J. Immunol. 32:2002;1164-1174 This paper studies six different transgenic mice - each expressing a germline or somatically mutated anti-dsDNA H chain, combined with one of three different L chains (Vκ1-Jκ1, Vκ4-Jκ4, Vκ8-Jκ5). B cells in these mice have varying outcomes of receptor editing or anergy, with the efficiency of L-chain editing apparently related to the physical position of the utilized Vκ gene segment.
20. Roark J.H., Kuntz C.L., Nguyen K.-A., Caton A.J., Erikson J. Breakdown of B cell tolerance in a mouse model of SLE. J. Exp. Med. 181:1995;1157-1167.
21. Martin F., Kearney J.F. Marginal-zone B cells. Nat. Rev. Immunol. 2:2002;323-335 This review is a critical synopsis of decades of studies on marginal zone B cells.
22. Radic M.Z., Mascelli M.A., Erikson J., Shan H., Weigert M. Ig H and L chain contributions to autoimmune specificities. J. Immunol. 146:1991;176-182.
23. Mandik-Nayak L., Bui A., Noorchashm H., Eaton A., Erikson J. Regulation of anti-double-stranded DNA B cells in nonautoimmune mice: localization to the T-B interface of the splenic follicle. J. Exp. Med. 186:1997;1257-1267.
24. Mandik-Nayak L., Seo S.-j., Sokol C., Potts K.M., Bui A., Erikson J. MRL-lpr/lpr mice exhibit a defect in maintaining developmental arrest and follicular exclusion of anti-double-stranded DNA B cells. J. Exp. Med. 189:1999;1799-1814.
25. Fields M.L., Sokol C.L., Eaton-Bassiri A., Seo s.-J., Madaio M.P., Erikson J. Fas/Fas Ligand deficiency results in altered localization of anti-double-stranded DNA B cells and dendritic cells. J. Immunol. 167:2001;2370-2378.
26. + T regulatory cells, providing an in vivo demonstration that T regulatory cells can inhibit T-cell help for B cells.
27. Mandik-Nayak L., Seo S.-j., Eaton-Bassiri A., Allman D., Hardy R.R., Erikson J. Functional consequences of the developmental arrest and follicular exclusion of anti-double-stranded DNA B cells. J. Immunol. 164:2000;1161-1168.
28. Cook M.C., Basten A., Fazekas de St. Groth B. Outer periarteriolar lymphoid sheath arrest and subsequent differentiation of both naive and tolerant immunoglobulin transgenic B cells is determined by B cell receptor occupancy. J. Exp. Med. 186:1997;631-643.
29. Chu Y., Taylor D., Yan H., Diamond B., Spatz L. Persistence of partially functional double-stranded (ds) DNA binding B cells in mice transgenic for the IgM. Int. Immunol. 14:2002;45-54 Tolerance to dsDNA is maintained in R4A IgM H chain Ig transgenic mice. However, anti-dsDNA B cells can be recovered as hybridomas, and in vitro culture of splenocytes with CD40L + IL-4 or with IL-4, -5, and -6 results in auto-Ab production, suggesting that T-cell help could activate these cells in vivo.
30. Tsao B.P., Chow A., Cheroutre H., Song Y.W., McGrath M.E., Kronenberg M. B cells are anergic in transgenic mice that express IgM anti-DNA antibodies. Eur. J. Immunol. 23:1993;2332-2339.
31. Xu H., Li H., Suri-Payer E., Hardy R.R., Weigert M. Regulation of anti-DNA B cells in recombination-activating gene-deficient mice. J. Exp. Med. 188:1998;1247-1254.
32. Roark J.H., Bui A., Nguyen K.-A., Mandik L., Erikson J. Persistence of functionally compromised anti-dsDNA B cells in the periphery of non-autoimmune mice. Int. Immunol. 9:1997;1615-1626.
33. Chen C., Nagy Z., Radic M.Z., Hardy R.R., Huszar D., Camper S.A., Weigert M. The site and stage of anti-DNA B cell deletion. Nature. 373:1995;252-255.
34. ••].
35. Rathmell J.C., Cooke M.P., Ho W.Y., Grein J., Townsend S.E., Davis M.M., Goodnow C.C. CD95 (Fas)-dependent elimination of self-reactive B cells upon interaction with CD4+ T cells. Nature. 376:1995;181-184.
36. Theofilopoulos A.N., Dixon F.J. Murine models of systemic lupus erythematosus. Adv. Immunol. 37:1985;269-390.
37. Friedmann D., Yachimovich N., Mostoslavsky G., Pewzner-Jung Y., Ben-Yehuda A., Rajewsky K., Eilat D. Production of high affinity autoantibodies in autoimmune New Zealand Black/New Zealand white F1 mice targeted with an anti-DNA heavy chain. J. Immunol. 162:1999;4406-4416.
38. Spatz L., Saenko V., Iliev A., Jones L., Geskin L., Diamond B. Light chain usage in anti-double stranded DNA B cell subsets: role in cell fate determination. J. Exp. Med. 185:1997;1317-1326.
39. ••].
40. ••].
41. Brard F., Shannon M., Prak E.L., Litwin S., Weigert M. Somatic mutation and light chain rearrangement generate autoimmunity in anti-single-stranded DNA transgenic MRL/lpr mice. J. Exp. Med. 190:1999;691-704.
42. Giese T., Davidson W.F. Evidence for early onset, polyclonal activation of T cell subsets in mice homozygous for lpr. J. Immunol. 149:1992;3097-3106.
43. Fields M.L., Seo S.-j., Nish S.A., Tsai J.H., Caton A.J., Erikson J. The regulation and activation potential of autoreactive B cells. Immunol. Res. 27:2002;219-234.
44. Vratsanos G.S., Jung S., Park Y.-M., Craft J. CD4+ T Cells from lupus-prone mice are hyperresponsive to T cell receptor engagement with low and high affinity peptide antigens: a model to explain spontaneous T cell activation in lupus. J. Exp. Med. 193:2001;329-337.
45. Bynoe M., Grimaldi C., Diamond B. Estrogen up-regulates Bcl-2 and blocks tolerance induction of naive B cells. Proc. Natl. Acad. Sci. U.S.A. 97:2000;2703-2708.
46. Grimaldi C., Michael D., Diamond B. Cutting edge: expansion and activation of a population of autoreactive marginal zone B cells in a model of estrogen-induced lupus. J. Immunol. 167:2001;1886-1890.
47. •].
48. Peeva E., Michael D., Cleary J., Rice J., Chen X., Diamond B. Prolactin modulates the naive B cell repertoire. J. Clin. Invest. 111:2003;275-285 The dosing of R4A Ig transgenic BALB/c mice with estrogen or prolactin results in a significant elevation of anti-dsDNA titers in the serum and recovery of anti-dsDNA B cells as hybridomas. These studies may help to explain the female predisposition in human systemic lupus erythematosus.
49. Putterman C., Limpanasithikul W., Edelman M., Diamond B. The double edged sword of the immune response: mutational analysis of a murine anti-pneumococcal, anti-DNA antibody. J. Clin. Invest. 97:1996;2251-2259.
50. Maldonado M.A., Kakkanaiah V., MacDonald G.C., Chen F., Reap E.A., Balish E., Farkas W.R., Jennette J.C., Madaio M.P., Kotzin B.L., et al. The role of environmental antigens in the spontaneous development of autoimmunity in MRL-lpr mice. J. Immunol. 162:1999;6322-6330.
51. Qian Y., Santiago C., Borrero M., Tedder T., Clarke S. Lupus-specific antiribonucleoprotein B cell tolerance in nonautoimmune mice is maintained by differentiation to B-1 and governed by B cell receptor signaling thresholds. J. Immunol. 166:2001;2412-2419.
52. Watanabe N., Nisitani S., Ikuta K., Suzuki M., Chiba T., Honjo T. Expression levels of B cell surface immunoglobulin regulate efficiency of allelic exclusion and size of autoreactive B-1 cell compartment. J. Exp. Med. 190:1999;461-470.
53. Hayakawa K., Asano M., Shinton S., Gui M., Wen L., Dashoff J., Hardy R. Positive selection of anti-thy-1 autoreactive B-1 cells and natural serum autoantibody production independent from bone marrow B cell development. J. Exp. Med. 197:2003;87-99 In a H + L chain Ig transgenic model for anti-thy-1 auto-Ab (ATA) B cells, high titers of serum ATA are detected, despite the finding that most ATA B cells show signs of negative selection. Serum ATA originates from B-1 B cells, providing evidence that the positive selection of autoreactive B-1 cells can be a separate pathway from that of development and selection of B-2 cells in the BM.
54. Borrero M., Clarke S. Low-affinity anti-Smith antigen B cells are regulated by anergy as opposed to developmental arrest or differentiation to B-1. J. Immunol. 168:2002;13-21 H + L chain Ig transgenic mice produce anti-Sm B cells with a lower affinity than anti-Sm B cells from H chain only transgenic mice. The B cells are phenotypically mature and of the B-2 subtype (in contrast to anti-Sm B cells in the H chain only model [51]), but appear functionally inactive as measured by decreased responsiveness to LPS in vitro. These data highlight the diverse outcomes revealed using distinct anti-Sm transgenic models.
55. Santulli-Marotto S., Qian Y., Ferguson S., Clarke S.H. Anti-Sm B cell differentiation in Ig transgenic MRL/Mp-lpr/lpr mice: altered differentiation and an accelerated response. J. Immunol. 166:2001;5292-5299.
56. Eisenberg R.A., Craven S.Y., Warren R.W., Cohen P.L. Stochastic control of anti-Sm autoantibodies in MRL/Mp-lpr/lpr mice. J. Clin. Invest. 80:1987;691-697.
57. Wang H., Shlomchik M.J. High affinity rheumatoid factor transgenic B cells are eliminated in normal mice. J. Immunol. 159:1997;1125-1134.
58. Wang H., Shlomchik M.J. Maternal Ig mediates neonatal tolerance in rheumatoid factor transgenic mice but tolerance breaks down in adult mice. J. Immunol. 160:1998;2263-2271.
59. Shlomchik M.J., Zharhary D., Saunders T., Camper S.A., Weigert M.G. A rheumatoid factor transgenic mouse model of autoantibody regulation. Int. Immunol. 5:1993;1329-1341.
60. Hannum L., Ni D., Haberman A., Weigert M., Shlomchik M. A disease-related rheumatoid factor autoantibody is not tolerized in a normal mouse: implications for the origins of autoantibodies in autoimmune disease. J. Exp. Med. 184:1996;1269-1278.
61. Wang H., Shlomchik M. Autoantigen-specific B cell activation in Fas-deficient rheumatoid factor immunoglobulin transgenic mice. J. Exp. Med. 190:1999;639-649.
62. William J., Euler C., Christensen S., Shlomchik M. Evolution of autoantibody responses via somatic hypermutation outside of germinal centers. Science. 297:2002;2066-2070 AM14 Tg rheumatoid factor (RF) B cells in lpr/lpr mice differentiate into Ab-forming cells (AFCs). Although there is no evidence for the RF B cells localizing in germinal centers (GCs), they are found proliferating at the bridging channels to the red pulp. Remarkably, microdissection and analysis of the AFC clusters reveals extensive somatic hypermutation in the RF Ig genes at this extra-GC site. In this way, autoreactive B cells may escape the normal processes of negative selection that occur in a structured germinal center.
63. Jacobson B.A., Panka D.J., Nguyen K.-A.T., Erikson J., Abbas A.K., Marshak-Rothstein A. Anatomy of autoantibody production: dominant localization of antibody-producing cells to T cell zones in Fas-deficient mice. Immunity. 3:1995;509-519.
64. Rifkin I., Leadbetter E., Beaudette B., Kiani C., Monestier M., Shlomchik M., Marshak-Rothstein A. Immune complexes present in the sera of autoimmune mice activate rheumatoid factor B cells. J. Immunol. 165:2000;1626-1633.
65. Leadbetter E.A., Rifkin I.R., Hohlbau A.H., Beaudette B.C., Shlomchik M.J., Marshak-Rothstein A. Chromatin-IgG complexes activate B cells by dual engagement of IgM and Toll-like receptors. Nature. 416:2002;603-607 Immune complexes (ICs) composed of nucleosomes and IgG Abs are stimulatory for RF B cells, as opposed to ICs that lack Toll-like receptor (TLR) ligands. It is further shown that this response is dependent on MyD88 and probably acts through the TLR9 pathway. This is a novel demonstration of how mammalian DNA can be rendered stimulatory via IC internalization and delivery to TLR9. It is hypothesized that the dual engagement of BCRs and TLRs may be a mechanism for SLE-associated autoreactive B-cell activation.
66. Rui L., Vinuesa C., Blasioli J., Goodnow C. Resistance to CpG DNA-induced autoimmunity through tolerogenic B cell antigen receptor ERK signaling. Nat. Immunol. 4:2003;594-600 In vitro culture with CpG can induce Ab-forming cell (AFC) formation in both naïve and anergic cells from the hen egg lysozyme (HEL) B-cell tolerance model. However, when chronically stimulated with HEL Ag, anti-HEL B cells are prevented from forming AFCs in the presence of CpG. This may reveal a mechanism by which anergic cells undergoing chronic Ag stimulation are prevented from differentiating into AFCs in response to Toll-like receptor signaling.
67. Healy J.I., Goodnow C.C. Positive versus negative signaling by lymphocytes antigen receptors. Annu. Rev. Immunol. 16:1998;645-670.
68. Doyle H., Mamula M. Post-translation protein modifications in antigen recognition and autoimmunity. Trends Immunol. 22:2001;443-449.
69. Shirota H., Sano K., Hirasawa N., Terui T., Ohuchi K., Hattori T., Tamura G. B cells capturing antigen conjugated with CpG oligodeoxynucleotides induce Th1 cells by elaborating IL-12. J. Immunol. 169:2002;787-794 Purified Ag-stimulated B cells are unable to stimulate Th1 cells to produce IFN-γ or induce a Th1-like phenotype in naïve T cells. However, if the Ag is conjugated with CpG, the B cells express increased levels of CD86, CD40, and MHC class II, secrete IL-12, and can induce T-cell differentiation into a Th1 phenotype. Thus, Ags containing TLR9 ligands may not only activate autoreactive B cells but also indirectly influence the direction of the associated T-cell response.
70. Litinskiy M., Nardelli B., Hilbert D., He B., Schaffer A., Casali P., Cerutti A. DCs induce CD40-independent immunoglobulin class switching through BLyS and APRIL. Nat. Immunol. 3:2002;822-829 Upon activation with IFN-γ, IFN-α, or CD40L, Ag-presenting cells can directly trigger class-switching in B cells in a CD40-independent but BlyS-dependent manner.
71. Plotz P. The autoantibody repertoire: searching for order. Nat. Rev. Immunol. 3:2003;73-78 This is a thoughtful review addressing why some auto-Ags are repeatedly targeted in human and mouse models of disease.
72. Prak E.L., Weigert M. Light chain replacement: a new model for antibody gene rearrangement. J. Exp. Med. 182:1995;541-548.
73. Li H., Jiang Y., Prak E.L., Radic M., Weigert M. Editors and editing of anti-DNA receptors. Immunity. 15:2001;947-957.
74. Wellmann U., Werner A., Winkler T.H. Altered selection processes of B lymphocytes in autoimmune NZB/W mice, despite intact central tolerance against DNA. Eur. J. Immunol. 31:2001;2800-2810.
75. Santulli-Marotto S., Retter M.W., Gee R., Mamula M.J., Clarke S.H. Autoreactive B cell regulation: peripheral induction of developmental arrest by lupus-associated autoantigens. Immunity. 8:1998;209-219.
76. Wardemann H., Yurasov S., Schaefer A., Young J., Meffre E., Nussenzweig M. Predominant autoantibody production by early human B cell precursors. Science. 301:2003;1374-1377 The authors of this paper estimated the pervasiveness of autoreactive Ab formation among immature B cells to be 55-75%. This strikingly high production of self-reactive B cells is not sustained in the mature B-cell pool where estimates for autoreactivity range from 4-22%. These data highlight the need for negative selection of autoreactive B cells and indicate several checkpoints where this can occur.